Mental Illness in Pregnancy and Lactation Flashcards

1
Q

Women’s reproductive life stages

A

Pre-menstrual
childbearing
Perimenopausal
Post menopausal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Estrogen

A

-Produced in the ovaries, fat cells and adrenal glands
-Estrogen stabilizes mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What happens to estrogen levels throughout the trimesters of pregnancy?

A

First Trimester:
Second Trimester:
Third Trimester:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens to Hormone Levels throughout the menstrual Cycle?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Progesterone

A

-Produced in the ovaries
-Increases MAO activity, boosting serotonin and GABA levels
-Inhibits neurotransmission
-Thickens lining of uterus to prepare for fertilization -“Pregnancy hormone”
-Progesterone is thought to be “excitotoxic” in the absence of estrogen (e.g. post-menopausal women, pregnancy)
-Destabilizes mood if levels low (e.g. irritability, anger or rage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Follicle Stimulating Hormone

A

Increases oestradiol production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Luteinizing Hormone

A

Stimulates production of estrogen and progesterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens to rates of depression with Menarche?

A

Depression rises with onset of menarche

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Premenstrual syndrome

A

Physical and emotional distress
Occurs 5 days prior to menstruation
Treated by PCP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Premenstrual Dysphoric Disorder

A

-Severe, debilitating form of physical and emotional distress
-1-2 weeks before menstruation occurs
-Treated in psychiatry(www.aafp.org)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Premenstrual Symptoms

A

Irritability
Feelings of sadness
Lack of motivation
Aggressiveness
Problems focusing and concentrating
Distress
Depression mixed with cognitive changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment of premenstruall symptoms

A

SSRIs
SNRIs
Quetiapine
Oral Contraceptives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Perimenopausal symptoms.

A

-Possible recurrence of depression and anxiety
-Higher risk of symptoms with history of premenstrual symptoms
-Abrupt Hormone levels fluctuate – Reduction of Estrogen
- “Domino effect”-Years of dysphoria with pre-menopause
– Dysphoric mood, sleep disturbance, fatigue, insomnia, hot flashes and multiple somatic
Complaints, memory problems, sexual dysfunction.
Mood changes are similar to pre-menstrual presentation but more persistent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Prescribing Psychotropics during pregnancy and lactation:

A

-Rates of depression vary during pregnancy and during the postpartum period
-Pregnant women with depression ( and the fetus) face many risks, with or without treatment.
-Consider Risks/ benefits on a case by case basis
-Major precautions should taken
-Estrogen changes during childbearing increase depression
-Fetal effects may occur with psychotropics
e.g. congenital malformations, fetal abnormalities, fetal withdrawal symptoms etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treating depression during pregnancy and lactation.

A

-No firm guidelines that can be generalized for this population
-Assess risks and benefits case by case
-Psychotherapy is a good option for mild depression
-Antidepressant use may outweigh the risks
-Treatment is encouraged for high-risk patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Presribing guidelines during pregnancy and lactation.

A

Identify concerns
Consultation is recommended
PMHNPs should not make the decisions for the woman
A mentally competent woman should make the decision about treatment

17
Q

Role of the PMHNP during pregnancy and lactation years.

A

The roles of PMHNPs may include:
To provide as much information as possible for the woman and partner
Drug Information must be evidence-based
Support the woman/partner in the decision making process
Support the woman’s final decision

18
Q

Prescribing for the fertile woman pre-pregnancy

A

Baseline information about the woman
Medication choice may be adjusted depending on the woman’s wishes
Choosing a safer drug
Medical evaluation

19
Q

Prescribing for the woman that wants to become pregnant. The roles of PMHNPs may include:

A

-Obtain baseline information
-Try a period of medication discontinuation
-Choosing medications with faster half-life
-Discuss pros and cons of medications
-Address potential complications that could arise
-Discuss the effects of not prescribing any medications
-Assess for any potential habits/behaviors
-Detailed documentation is important
-Careful considerations during first trimester.
-Consider non-pharmacological interventions
-Consider electro convulsant therapy (ECT)
-Use lower doses if needed
-Involve partner as necessary
-Avoid polypharmacy
-Avoid high risk medications

20
Q

Current Pregnancy and Lactation Labeling

A

Narrative
Risk Summary
Clinical Considerations
Data
No longer using A,B,C,D,X

21
Q

Treating depression during pregnancy

A

Consider certain TCAs and SSRIs
Avoid prescribing Paroxetine (Paxil)
Consider ECT
Hospitalization

22
Q

Treating anxiety during pregnancy and lactation.

A

-Treat with non-pharmacological methods (e.g. psychotherapy)
-If necessary, benzodiazepines may be used
-Avoid benzodiazepines during the first trimester due to cleft anomalies in babies
-Clonazepam may be a good choice
-Gradual discontinuation is required

23
Q

Treating bipolar during pregnancy and Lactation.

A

-Emphasize effects of mood stabilizers
-Avoid fetus exposure to mood stabilizers in first trimester
-Exposure to Lithium in first semester can lead to Ebstein’s anomaly
-Lithium, Carbamazepine and Valproic acid must be avoided in first trimester
-High risk of fetal malformations such as spina bifida and neural tube defects
-If necessary, they may be used in second and third trimesters
-Folate supplementation is recommended
-Frequent monitoring is required
-Limited data available with Lamotrigine and Topiramate

24
Q

Treating psychotic disorders during pregnancy and lactation:

A

-Several antipsychotics have not been studied. But the potential benefits outweigh the risks.
-Typical antipsychotics are recommended (e.g. Haloperidol, Chlorpromazine and Trifluoperazine)
-Olanzapine, quetiapine, risperidone, clozapine associated with low weight babies and abortion
-According to the FDA, Clozapine has the lowest risk to the fetus
-Atypical antipsychotics have been linked to gestational diabetes

25
Q

Considerations during the Post-partum period:

A

Monitor for signs of post partum depression/psychosis
If mood stabilizers were discontinued during pregnancy, re-start medications
All psychotropic medications enter the breast milk
High risk time for women d/t large drop in estrogen levels
Assess for prior history of depression
High incidence of “baby blues”
Moderate to low incidence of depressive or psychotic episodes

26
Q

Prescribing antidepressants during post-partum period

A

Antidepressants may be used
Sertraline and Paroxetine are desired choices
Avoid Fluoxetine
Limited data available on other antidepressants
Many newer antidepressants have case reports demonstrating safety
Low-dose monotherapy, is the safest approach

27
Q

Untreated depression risks:

A

-Suicide/infanticide
-Malnutrition
-Poor infant care, neglect
-Neonatal irritability
-Poor bonding/attachment
-Possible increased risk for maternal substance abuse

28
Q

Prescribing anti-anxiety drugs during post-partum period.

A

Consider risk/benefits:
-Increased incidence during pregnancy rather than post-partum
-Use of antidepressants vs. benzodiazepines

Benzodiazepines
-Diazepam can cause oral defects
-Lorazepam and clonazepam are safer
-Neonatal withdrawal syndrome common-taper medication prior to delivery

Lactation Case Reports:
Reports of sedation, hypotonia, withdrawal after stopping breastfeeding

29
Q

Mood stabilizer prescribing in the post-partum period.

A

Treatment may be required for bipolar disorder
Several mood stabilizers have been linked to potential complications
Carbamazepine has been associated with liver problems
Valproic acid may be a safer option
Lithium is contraindicated d/t cardiac effects: Epstein’s anomaly
Depakote and Tegretol can cause neural tube defects
Can supplement with folate and Vit K
Use of antipsychotics is recommended rather than these agent

30
Q

Prescribing antipsychotics during the post-partum period.

A

-Consider risk/benefits
-Typical antipsychotics have been used
-Olanzapine and Risperidone may be used
-Clozapine is contraindicated
-Risk for teratogenicity high in the first trimester
-May want to taper prior to delivery
-High-potency formulations minimize side effects

31
Q

Assessing risk vs. Benefit ratio in pregnancy and lactation.

A

Case report evidence:
– Up to 1/3 or women receive psychotropics during pregnancy
– Non-pharmacologic interventions should be the first line of treatment
– If off medications for pregnancy-may start prophylactic treatment if post-partum relapse
– Some medications should be tapered 3 weeks prior to delivery to prevent withdrawal in newborn

Lactation:
– Less protein bound and more lipid-soluble-more likely to pass into breast milk

32
Q

Risk of psychopharmacology during pregnancy and Lactation:

A
  • Spontaneous abortion or premature labor
    – Toxicity or withdrawal symptoms in neonate
    – Alterations in physiology of mother
    – Morphological teratogenicity
    – Behavioral teratogenicity
    -Risks are weighed with the untreated mental illness risks